These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 7078802

  • 1. [Immunological aspects in the treatment of malignant melanoma].
    Cascinelli N, Vaglini M, Rovini D, Orefice S, Marolda R, Veronesi U.
    Minerva Med; 1982 Apr 28; 73(18):1233-40. PubMed ID: 7078802
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Current concepts in the management of malignant melanoma.
    Lichtenfeld JL.
    Am J Med Sci; 1976 Apr 28; 272(2):185-95. PubMed ID: 1008080
    [No Abstract] [Full Text] [Related]

  • 4. [Results in the use of immunochemotherapy in patients with cutaneous malignant melanoma].
    Calbo L, Gorgone S, Palmeri R, Salibra M, Melita P.
    Chir Ital; 1983 Aug 28; 35(4):519-25. PubMed ID: 6680859
    [Abstract] [Full Text] [Related]

  • 5. [Experience with adjuvant chemoimmunotherapy with DTIC and BCG in malignant melanoma (author's transl)].
    Pullmann H, Muth M.
    Z Hautkr; 1982 Feb 15; 57(4):294-7. PubMed ID: 7080583
    [No Abstract] [Full Text] [Related]

  • 6. [Results of immunochemotherapy in malignant melanoma].
    Duchková H, Richter J, Kubíková M, Peska J, Ragan J, Vohryzková E, Hrivnáková J, Kvasnicka J.
    Cesk Dermatol; 1980 Aug 15; 55(4):277-80. PubMed ID: 7407970
    [No Abstract] [Full Text] [Related]

  • 7. Letter: Chemoimmunotherapy of malignant melanoma.
    N Engl J Med; 1975 Jan 16; 292(3):159-60. PubMed ID: 1196343
    [No Abstract] [Full Text] [Related]

  • 8. [Multiple BCG-induced ulcers after subcutaneous vaccination in the framework of immunochemotherapy in malignant melanoma].
    Korting HC, Strasser S, Konz B.
    Hautarzt; 1988 Mar 16; 39(3):170-3. PubMed ID: 3378889
    [Abstract] [Full Text] [Related]

  • 9. Endolymphatic BCG therapy in the rabbit VX2 tumor.
    Edwards JM, O'Donnell TF, Johnson H, Rutt D, Kinmonth JB.
    Surg Forum; 1975 Mar 16; 26():147-9. PubMed ID: 1216093
    [No Abstract] [Full Text] [Related]

  • 10. [Adjuvant chemotherapy in malignant melanoma after pretherapeutic sensitivity testing].
    Zaumseil RP, Wohlrab W, Fiedler H, Wozniak KD.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981 Mar 16; 108(5):721-4. PubMed ID: 6172340
    [No Abstract] [Full Text] [Related]

  • 11. Immunotherapy for recurrent malignant melanoma: efficacy of BCG in prolonging the postoperative disease-free interval and survival.
    Gutterman JU, Richman SP, McBride CM, Burgess MA, Bartold SL, Kennedy A, Gehan EA, Mavligit G, Hersh EM.
    Recent Results Cancer Res; 1978 Mar 16; 68():359-62. PubMed ID: 752870
    [No Abstract] [Full Text] [Related]

  • 12. Intralymphatic and regional surgical adjuvant immunotherapy in high-risk melanoma of the extremities.
    Ariyan S, Kirkwood JM, Mitchell MS, Nordlund JJ, Lerner AB, Papac RJ.
    Surgery; 1982 Sep 16; 92(3):459-63. PubMed ID: 7112396
    [Abstract] [Full Text] [Related]

  • 13. Results of adjuvant BCG immunotherapy in malignant melanoma.
    Wätzig V, Knopf B.
    Arch Geschwulstforsch; 1981 Sep 16; 51(6):493-6. PubMed ID: 7332442
    [Abstract] [Full Text] [Related]

  • 14. [Recent controlled studies on the therapy of malignant melanoma].
    Canavese G, Margarino G.
    Minerva Med; 1982 Dec 15; 73(48):3458-60. PubMed ID: 6757800
    [No Abstract] [Full Text] [Related]

  • 15. [Malignant melanoma].
    Minerva Med; 1981 Apr 28; 72(17):1095-8. PubMed ID: 7231768
    [No Abstract] [Full Text] [Related]

  • 16. Adjuvant immunotherapy of malignant melanoma.
    Aranha GV, McKhann CF, Grage TB, Gunnarsson A, Simmons RL.
    Cancer; 1979 Apr 28; 43(4):1297-303. PubMed ID: 445331
    [Abstract] [Full Text] [Related]

  • 17. Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology Group.
    Agarwala SS, Neuberg D, Park Y, Kirkwood JM.
    Cancer; 2004 Apr 15; 100(8):1692-8. PubMed ID: 15073858
    [Abstract] [Full Text] [Related]

  • 18. Adjuvant therapy in malignant melanoma: a trial of immunotherapy. chemotherapy, and combined treatment.
    Kaufman SD, Cosimi AB, Wood WC, Carey RW.
    Recent Results Cancer Res; 1978 Apr 15; 68():380-6. PubMed ID: 752874
    [No Abstract] [Full Text] [Related]

  • 19. Experiences in adjuvant immunotherapy of melanoma with BCG substrain Jena S 4.
    Wätzig V, Zureck A.
    Dev Biol Stand; 1986 Apr 15; 58 ( Pt A)():461-4. PubMed ID: 3297877
    [No Abstract] [Full Text] [Related]

  • 20. Endolymphatic isotope and BCG in the management of malignant melanoma.
    Edwards JM, Pheils PJ.
    Aust N Z J Surg; 1978 Feb 15; 48(1):40-8. PubMed ID: 276347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.